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Abstract
Background. Blood transfusion has been reported as an independent risk factor for poor outcome after liver resection in
spite of its well known benefits. Refinements in parenchymal dissection have been pursued to reduce blood loss and
transfusion. A collagen-sealing device (CSD) has recently been touted as an alternative technique that aids in blood
conservation. We report the results of our initial series of patients undergoing a CSD-assisted resection and present a
historical comparison. Patients and methods. Consecutive patients who were undergoing liver resection at a single tertiary
cancer centre were enrolled in this study. The Ligasure Atlas device (Valleylab Inc., Division of Tyco Healthcare) was used
for parenchymal division in the CSD group. Known blood conservation techniques (i.e. low central venous pressure,
ultrasonic dissection, Pringle clamp) were standardized in both groups. Clinical and outcome variables including operative
time, estimated blood loss and transfusion requirements were collected. All statistical analyses were performed with SAS
version 8.2e. Results. In all, 28 consecutive patients underwent CSD-assisted hepatic resection between October 2003 and
September 2004. The control group included 188 patients treated between January 1991 and September 2003. In the CSD
group, we observed a reduction in mean estimated blood loss (930 vs 1450 ml, p/0.002) and mean transfusion
requirements (0.46 vs 1.19 units, p/0.002). There was no increase in operative time with the new instrument (326 vs 363
min, p/0.167). Discussion. Use of a CSD has the potential to further reduce blood loss and transfusion requirements
without increasing operative time.
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Introduction
In spite of their therapeutic role, blood transfusions
have been reported as an independent risk factor for
operative mortality, major complications and length
of hospital stay in patients undergoing liver resec-
tion for colorectal metastases [1]. This effect has
been found to occur in a dose-dependent fashion
and justifies efforts to find ways of decreasing the
frequency and number of units of blood transfused
to patients.
Efforts to minimize blood loss during parenchymal
dissection can be classified into three groups. First,
strategies have been directed at minimizing blood flow
through the liver during parenchymal dissection (e.g.
Pringle manoeuvre). Second, anaesthetic techniques
are applied to achieve low central venous pressure
(CVP) during parenchymal dissection to reduce blood
pressure in the hepatic vessels. Third, a wide range of
strategies have been directed at minimizing blood loss
along the plane of transection. In most cases, combi-
nations of these strategies are used to achieve minimal
blood loss.
We have employed a feedback-controlled collagen-
sealing device (CSD) with the aim of minimizing
blood loss during parenchymal dissection (see Figure
1). This device makes use of bipolar electro-thermal
energy to create a permanent seal of collagen and
elastin between opposing walls of both bile ducts and
blood vessels. Seals can be attempted with current
devices on structures up to 7 mm in diameter. Larger
vessels require formal suturing or stapling. The CSD
can be used without isolating the bile ducts and blood
vessels.
Horgan reported the efficacy and safety of the use
of the CSD for liver resection in 2001 [2]. It was
subsequently reported that use of the CSD could be
achieved with a low rate of bile leak and reduced
need for inflow occlusion [3]. We report the results
of our initial series of patients undergoing a new
CSD-assisted resection and present a historical
comparison.
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Patients and methods
Patient selection
A prospectively maintained database was used to
identify all patients who underwent liver resection
between October 2003 and September 2004 at a
tertiary care centre. Patients were included in the
study if the CSD (Ligasure AtlasTM, Valleylab Inc.,
Division of Tyco Healthcare) was used to assist in
parenchymal dissection. The same database was
used to gather data on consecutive liver resections
from 1 January 1991 until 30 September 2003;
these patients made up the historical control cohort
in which the CSD was not used. Known blood
conservation techniques (i.e. Pringle manoeuvre,
low CVP, aprotinin administration and ultrasonic
dissection) were standardized in both groups and
liver resections were performed by the same sur-
geons (S.H., A.S. and C.H.L.). Cases were ex-
cluded from the study if they included multivisceral
resections.
Liver resection technique
Liver resections were performed using the Minimal
Blood Loss (MBL) Programme, which was described
in our earlier publication [4]. Adjunct peri-operative
techniques included maintaining CVP below 6.0
mmHg via fluid restriction, no positive end expiratory
pressure (PEEP) and no intermittent positive pressure
(IPP) to prevent ventilatory effects on CVP, aprotonin
administration (2/106 unit bolus, 500 000 units per
hour thereafter) and use of a cell saver device.
The operative technique began with complete in-
flow occlusion using precise portal dissection to
identify the inflow artery and portal vein. These
structures would be divided using a vascular stapling
device or suture. Once appropriate lines of ischaemic
demarcation were confirmed, outflow occlusion was
initiated. Firstly, the retro-hepatic veins were indivi-
dually ligated and then the ipsilateral hepatic vein was
identified and divided using a vascular stapling device.
The middle hepatic vein was also identified and
ligated extrahepatically when appropriate. Once vas-
Figure 1. Collagen-sealing device (CSD) in use during parenchymal dissection.
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cular inflow and outflow occlusion were satisfactory,
parenchymal dissection commenced, using the Cavi-
tron Ultrasonic Surgical Aspirator (CUSA) dissector.
Clips or suture were used in the pre-CSD era, and the
CSD technique is described below. Pringle clamp was
used during parenchymal dissection and the protocol
involved a maximum of 20 min clamp time followed
by a 5 min break. This could be repeated as needed
for the resection.
CSD
The CSD used at our centre was the LigaSure AtlasTM
20 cm Sealer/Divider (Valleylab Inc.). This shortened
version of the laparoscopic equivalent was equipped
with a cutting blade that avoided the need for an
additional cutting step after sealing. The instrument
was used with and without prior parenchymal dissec-
tion with the CUSA. The potential for time saving by
foregoing preliminary dissection with the CUSA must
be balanced with the subsequent need to crush and
seal larger amounts of tissue. This crushing can result
in the tearing of small bile ductules and vessels if
excessive volumes of liver tissue are crushed between
the blades of the instrument. We were able to over-
come this limitation by partially closing the instru-
ment prior to gently inserting the lower blade into the
liver parenchyma. This helped to ensure that the
penetrating blade was inserted parallel to the previous
line of seal and also limited the amount of tissue
incorporated in each seal. If resistance was encoun-
tered during insertion of the lower blade into the liver
parenchyma, a blunt clamp was used to first create a
tunnel for the CSD as described by Strasberg et al.
[3]. Periodic cleaning of the blades with hydrogen
peroxide helped to reduce sticking of tissue to the
instrument during removal. We felt that there was
no benefit of activating the device prior to full closure
of the blades as this practice encourages excessive
crushing.
Data collection/outcomes
Demographic data were obtained from the prospec-
tive electronic database. Clinical data were then
abstracted by chart review of both electronic and
paper records. Demographic data included age and
sex. Clinical data sources included operative, post-
operative, pathology and transfusion records. Opera-
tive data collected included date of surgery, type of
resection, operative time, use of the CUSA, use of the
CSD (LigaSure), use of the cell saver device, and
estimated blood loss. Estimated blood loss was
determined by standard protocol of measurement of
intraoperative suction with subtracted irrigation fluids
and surgical sponge weights. Postoperative data in-
cluded incidence of postoperative bile leak, bleeding
complication requiring operative re-exploration and
length of stay from date of surgery. Pathology reports
were used to confirm final diagnoses. Transfusion
data included number of units of allogeneic blood
transfused perioperatively.
Statistical analysis
Mean estimated blood loss, operative time, and
required units of blood transfusion in the historical
and CSD groups were compared using Student’s t
test. Median estimated age, CVPs and length of stay
were compared using the Wilcoxon rank sum test.
Requirement of any blood transfusion was compared
using Fisher’s exact test and the distribution of
resections and diagnoses were compared using Pear-
son’s x2 test. All statistical analyses were performed
with SAS version 8.2e (SAS Institute, Cary, NC,
USA).
Results
A total of 34 consecutive patients underwent CSD-
assisted hepatic resection between October 2003 and
September 2004 at a tertiary cancer centre. Six of
these patients required multivisceral resections and
were excluded from the study. Five patients under-
went hepatic resection during the study period but
were not included in our study as the CSD equipment
was not available for these resections. The control
group included 188 consecutive patients treated
between January 1991 and September 2003 at the
same centre. Overall cohort characteristics are sum-
marized in Table I.
The median age of patients in the CSD group was
higher than in the control group (73.8 vs 64.0 years,
pB/0.0001). In addition, the ratio of males to females
was different between the comparison groups. The
extent of resections performed and indications for
surgery (diagnosis) were not different and both groups
had resections under low CVP conditions (4.0 vs
Table I. Overall cohort characteristics.
Parameter Value
Sample size 216
Demographics
Median age 65.4
Gender (% male) 56.9%
Extent of resections performed (%)
1 segment 16 (7.4)
2 segments 57 (26.4)
Lobectomy 115 (53.2)
Extended resection 28 (13.0)
Diagnosis (%)
Colorectal metastases 137 (63.4)
Hepatocellular carcinoma 23 (10.7)
Benign disease 28 (13.0)
Other 28 (13.0)
Median CVP* (mmHg) 3.0
*Median central venous pressure during parenchymal dissection.
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3.0 mmHg, p/0.299). Both groups were compared
(where data was available) for differences in baseline
liver function. They had similar baseline INR, platelet
counts and bilirubin levels. Although INR did differ
statistically, this was not clinically significant (median
INR 0.99 vs 0.95, p/0.01). Cohort comparisons are
summarized in Table II.
In the CSD group, we observed a reduction in
mean estimated blood loss (930 vs 1450 ml, p/
0.002). In spite of the fact that requirement for
transfusion was not significantly reduced in the CSD
group (26.6 vs 33.7%, p/0.671), the mean number
of units transfused was reduced (0.46 vs 1.19 units,
p/0.002). There was no increase in operative time
observed with use of the new instrument (326 vs
363 min, p/0.167). The median length of stay from
date of surgery was not significantly different between
the two groups (7.0 vs 8.0 days, p/0.101). The
comparison of primary outcomes is summarized in
Table III.
When the two groups were compared with regard
to postoperative complications (Table IV) there were
no observed differences in the incidence of bile leak
(3.6 vs 10.0%, p/0.238) and no bleeding complica-
tions were observed in either group.
Discussion
Use of the CSD technology is currently reported
in many surgical subspecialties. General surgical
applications have included both open and mini-
mally invasive procedures in colorectal (colectomy
and haemorroidectomy) [513], head and neck
[14,15] and splenic surgery [16]. Hepatobiliary ap-
plications of the CSD have included pancreaticoduo-
denectomy [17] and liver resection [2,3]. In
particular, the use of the CSD in hepatic resections
is potentially advantageous as it seals both biliary and
vascular structures. In an unpublished case report,
Slakey described the use of the CSD along with the
CUSA in performing a left lateral segmentectomy for
a living donor operation [D. Slakey, unpublished
observations]. The CSD was used for division of the
falciform ligament as well as intrahepatic structures
skeletonized by the CUSA. Subsequently, Strasberg
and Horgan reported their preliminary experience
with the use of the CSD in liver resection [2,18].
Horgan used the CSD after parenchymal dissection
using the ultrasonic aspirator. In six consecutive cases
(three right hepatectomies, two left hepatectomies
and one segment 2,3 resection), blood loss ranged
from 425 to 700 ml and there were no morbidities and
mortalities. Strasberg et al. later reported the results
of their case-series of 27 hepatic procedures [3]. They
found that the CSD worked effectively for 23 of the
procedures where standard parenchymal transections
were performed. In their experience, the instrument
did not function well for hepatic enucleations. In the
standard parenchymal transections median blood loss
was 500 ml (range 1002500 ml) and only four
patients required blood transfusion. The 30-day
mortality was zero and the one postoperative death
was due to pulmonary complications. None of the
patients who underwent standard parenchymal trans-
ections suffered bile leaks and there were no patients
whose postoperative course was complicated by blood
loss. They concluded that the CSD could be used
safely and effectively for standard liver resections as
both bile leak and postoperative bleeding were not
Table II. Comparative analysis  cohort characteristics.
Parameter CSD Control p value
Sample size 28 188 
Demographics
Age (median, years) 73.8 64.0 B/0.0001
Gender (% male) 75.0 54.2 0.029
Type of resections performed (%)
1 segment 1 (3.6) 15 (8.0) 0.334
2 segments 5 (17.9) 52 (27.7)
Lobectomy 16 (57.1) 99 (52.7)
Extended resection 6 (21.4) 22 (11.7)
Diagnosis (%)
Colorectal metastases 16 (54.8) 121 (64.4) 0.204
Hepatocellular carcinoma 6 (19.4) 17 (9.0)
Benign disease 2 (9.7) 26 (13.8)
Other 4 (16.1) 24 (12.8)
Baseline liver function (%)
INR (median) 0.99 (n/24) 0.95 (n/83) 0.01
Initial platelet count (median, /109/L) 225 (n/26) 231 (n/93) 0.74
Intitial bilirubin (median, mmol/L) 8.0 (n/23) 8.0 (n/75) 1.00
Median CVP* (mmHg) 4.0 3.0 0.299
*Median central venous pressure during parenchymal dissection.
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encountered in their series and need for inflow
occlusion was infrequent with CSD use.
The only comparative analysis completed to date
considered liver resection with a combination of a
monopolar floating ball plus CSD (FB-LS; n/16)
against matched historical controls that underwent
liver resection by the clamp-crushing method and
Pringle manoeuvre (CC; n/16) [19]. They found a
significantly reduced blood loss in the FB-LS group
compared with the CC group (during transection:
200 vs 480 ml, p/0.006; total: 300 vs 730 ml, p/
0.008). However, median liver transection time was
long in the FB-LS group compared with the CC
group (144 vs 58 min, pB/0.0001). Inflow occlusion
was used in five of the patients in the FB-LS group.
No patient in the FB-LS group suffered a bile leak
while one patient in the CC group was found to have a
bile leak.
Our study compared two cohorts that differed
primarily in the use of the CSD. The historical control
group was drawn from a population after which a
minimal blood loss strategy had been implemented in
our centre, establishing the use of low CVP anaes-
thesia, ultrasonic dissector (CUSA), and cell saver as
standard for most cases [4]. Although the comparison
groups differed in age and gender compositions, the
extent of resection and indications for surgery as well
as baseline liver function were comparable. We
observed a reduction in mean estimated blood loss
when the CSD group was compared to the control
group (930 vs 1450 ml, p/0.002) and a decrease in
mean transfusion requirements (0.46 vs 1.19 units,
p/0.002) was observed. We were unable to demon-
strate a difference in total operative time between the
two groups (326 vs 363 min, p/0.167), although
with a larger sample size the observed difference may
have reached statistical significance. That said, use of
the CSD did not result in an increased mean operative
time as reported in the previous comparative analysis
[19]. Mean results for estimated blood loss, number
of units transfused and total operative time were
reported in this study as it was felt that outliers played
a significant role in patient outcome after liver
resection.
In this study, we considered complications that
might be associated with a failure of CSD to
effectively seal bile ducts and blood vessels. There
was no observed difference between the comparison
groups when the rates of bile leak and bleeding
complications were considered. This is in clear agree-
ment with previous reports of the safety of this device
in liver resection. In addition, despite the fact that the
median age was significantly greater in the CSD
group, median length of hospital stay was shorter in
this group.
A further benefit of this instrument is the avoidance
of surgical clipping. This allows for detailed post-
operative follow-up imaging unhindered by artifacts
associated with metallic clips. This is becoming more
important in the evolution of new and effective
chemotherapies for metastatic disease, allowing
further extended and staged resections.
Conclusion
Use of a CSD during parenchymal transaction of liver
resections appears to be a safe and efficient approach
to further reduce blood loss and transfusion require-
ments without increasing operative time. This method
warrants further study at multiple centres to confirm
our findings.
Acknowledgements
Dr. Calvin Law is a Carrer Scientist of the Ontario
Ministry of Health and Long-Term Care and is
supported through a Health Research Personnel
Development-Carrer Scientist Award.
References
[1] Kooby DA, Stockman J, Ben Porat L, Gonen M, Jarnagin
WR, Dematteo RP, et al. Influence of transfusions on
perioperative and long-term outcome in patients following
hepatic resection for colorectal metastases. Ann Surg 2003;/
237:/8609.
[2] Horgan PG. A novel technique for parenchymal division
during hepatectomy. Am J Surg 2001;/181:/2367.
[3] Strasberg SM, Drebin JA, Linehan D. Use of a bipolar vessel-
sealing device for parenchymal transection during liver sur-
gery. J Gastrointest Surg 2002;/6:/56974.
[4] Bui L, Smith AJ, Bercovici M, Szalai JP, Hanna SS. Minimis-
ing blood loss and transfusion requirements in hepatic resec-
tion. HPB 2002;/4:/510.
[5] Clinical Outcomes of Surgical Therapy Group. A comparison
of laparoscopically assisted and open colectomy for colon
cancer. N Engl J Med 2004;350:20509.
[6] Whelan RL. Should carcinoma of the colon be treated
laparoscopically? Point Surg Endosc 2004;/18:/85762.
Table III. Comparative analysis  primary outcomes.
Parameter CSD Control p value
Sample size 28 188 
Mean EBL (ml) 930.4 1449.8 0.002*
Mean transfusion requirement
(no. of units)
0.46 1.19 0.002*
Any transfusion requirement (%) 8 (26.6) 64 (33.7) 0.671
Operative time 326.3 363.3 0.167
Median length of stay (days)$ 7.0 8.0 0.101
*pB/0.05.
$Measured from date of surgery.
Table IV. Comparative analysis  postoperative complications.
Parameter CSD Control p value
Sample size 28 188 
Bile leak (%) 1 (3.6) 19 (10.0) 0.238
Bleed (%) 0 (0.0) 0 (0.0) 
*pB/0.05.
198 T. Cheang et al.
[7] Hasegawa H, Watanabe M, Nishibori H, Ishii Y, Kitajima M.
Clipless laparoscopic restorative proctocolectomy using an
electrothermal bipolar vessel sealer. Digestive Endoscopy
2003;/15:/3202.
[8] Chung YC, Wu HJ. Clinical experience of sutureless closed
hemorrhoidectomy with LigaSure. Dis Colon Rectum 2003;/
46:/8792.
[9] Franklin EJ, Seetharam S, Lowney J, Horgan PG. Rando-
mized, clinical trial of Ligasure vs conventional diathermy in
hemorrhoidectomy. Dis Colon Rectum 2003;/46:/13803.
[10] Jayne DG, Botterill I, Ambrose NS, Brennan TG, Guillou PJ,
O’Riordain DS. Randomized clinical trial of Ligasure versus
conventional diathermy for day-case haemorrhoidectomy. Br J
Surg 2002;/89:/42832.
[11] Milito G, Gargiani M, Cortese F. Randomised trial comparing
LigaSure haemorrhoidectomy with the diathermy dissection
operation. Tech Coloproctol 2002;/6:/1715.
[12] Palazzo FF, Francis DL, Clifton MA. Randomized clinical
trial of Ligasure versus open haemorrhoidectomy. Br J Surg
2002;/89:/1547.
[13] Sayfan J, Becker A, Koltun L. Sutureless closed hemorrhoi-
dectomy: a new technique. Ann Surg 2001;/234:/214.
[14] Kiriakopoulos A, Dimitrios T, Dimitrios L. Use of a
diathermy system in thyroid surgery. Arch Surg 2004;/139:/
9971000.
[15] Petrakis IE, Kogerakis NE, Lasithiotakis KG, Vrachassotakis
N, Chalkiadakis GE. LigaSure versus clamp-and-tie thyroi-
dectomy for benign nodular disease. Head Neck 2004;/26:/
9039.
[16] Romano F, Caprotti R, Franciosi C, De Fina S, Colombo G,
Uggeri F. Laparoscopic splenectomy using Ligasure. Preli-
minary experience. Surg Endosc 2002;/16:/160811.
[17] Belli G, Fantini C, Ciciliano F, D’Agostino A, Barberio M.
Pancreaticoduodenectomy in portal hypertension: use of
the Ligasure. J Hepatobiliary Pancreat Surg 2003;/10:/215
17.
[18] Strasberg SM. Use of the LigaSure vessel sealing system in
Whipple and liver resection. American College of Surgeons
Annual Meeting, Chicago, IL, 2000.
[19] Sakamoto Y, Yamamoto J, Kokudo N, Seki M, Kosuge T,
Yamaguchi T, et al. Bloodless liver resection using the
monopolar floating ball plus ligasure diathermy: preliminary
results of 16 liver resections. World J Surg 2004;/28:/
16672.
Collagen-sealing device in hepatic resection 199
